Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026)
Tenaya Therapeutics' quarterly Non Operating Income came in at $793000.0 in Q1 2026, up 1933.33% year-on-year from $39000.0 in Q1 2025, and up 3072.0% quarter-over-quarter from $25000.0 in Q4 2025.
Tenaya Therapeutics has reported Non Operating Income for 7 years, with the latest figure at $793000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 1933.33% year-over-year to $793000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 30.74% YoY), and the FY2025 full-year result was $52000.0, down 36.59% from the prior year.
- Non Operating Income for Q1 2026 stood at $793000.0, up from $25000.0 in the prior quarter.
- The five-year high for Non Operating Income was $2.0 million in Q1 2023, with the low at -$16000.0 in Q2 2025.
- Average Non Operating Income over 5 years is $501823.5, with a median of $98000.0 recorded in 2022.
- Year-over-year, Non Operating Income soared 107600.0% in 2024 and sank 1500.0% in 2025.
- Tracing TNYA's Non Operating Income over 5 years: stood at -$3000.0 in 2022, then jumped by 50466.67% to $1.5 million in 2023, then slumped by 99.74% to $4000.0 in 2024, then soared by 525.0% to $25000.0 in 2025, then jumped by 3072.0% to $793000.0 in 2026.
- The last three Non Operating Income figures came in at $793000.0 (Q1 2026), $25000.0 (Q4 2025), and $661000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | 793,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 661,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 602,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | 38,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | 161,000.00 |
| Sep 30, 2020 | 157,000.00 |
| Jun 30, 2020 | 180,000.00 |